^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    rosmantuzumab (OMP-131R10)

    i
    Other names: OMP-131R10, OMP 131R10
    Associations
    News
    Trials
    Company:
    Mereo Biopharma
    Drug class:
    Protein kinase modulator, RSPO3 inhibitor
    Associations
    News
    Trials